Antibody · Molecular design
Co-designing antibody properties
Bring binding, molecular stability and developability into a shared design process, connecting sequence exploration, structural assessment and experimental feedback.
Explore antibody candidates through generative modeling and multi-property assessment. Bring research constraints into early design and use computational screening and functional validation to guide successive iterations.
3 weeks
Candidate screening completedHER-2 case 0.74 nM
Predicted KD of the best antibodyHER-2 case · predicted · Herceptin 1.44 nM >20%
Validated hit rateHER-2 case · experimental validation 40%
Higher tumor-cell killing than Herceptin in CDCHER-2 case · one candidate · in vitro CDC assay
Research focus: antibody design and functional assessment


